26 May 2022
Meningitis is a challenging disease that is responsible for hundreds of thousands of deaths each year. In this presentation, Professor Richard Moxon, Emeritus Professor of Paediatrics at Oxford University, discusses how safe and effective vaccines against the major forms of bacterial meningitis have been developed, and the challenges associated with their implementation in many countries. This talk was presented at the SelectScience® Virtual Microbiology and Infectious Disease Summit 2022.
University of Oxford
Richard Moxon MA, F.Med.Sci, FRS is Emeritus Professor of Paediatrics and a Professorial Fellow of Jesus College at the University of Oxford. His paediatric and research training was in the UK (1966-1969) and the USA (1970-1974). He was Assistant and then Associate Professor of Paediatrics at Johns Hopkins University in Baltimore (1974-1984), becoming the Eudowood Director of Pediatric Infectious Diseases in 1981 before he was elected as Action Research Professor and Chairman of Paediatrics at Oxford University (1984 - 2008) and Head of the Molecular Infectious Diseases Group in the Weatherall Institute of Molecular Medicine (1988-2008). He is a Fellow of the UK Royal College of Paediatrics and Child Health and of the UK Academy of Medical Sciences and was elected a Fellow of the Royal Society in 2007. His major research interests have been on the pathogenesis and prevention of sepsis and meningitis caused by the bacteria Haemophilus influenzae and Neisseria meningitidis.